Selexipag as a Therapeutic Alternative for Treprostinil‐Induced Thrombocytopenia in Pulmonary Arterial Hypertension: A Case Report
Year: 2026
Type: article
Study design: Case Report
Abstract: Parenteral prostacyclin pathway agent-induced thrombocytopenia may require dose reduction or therapy discontinuation to mitigate the adverse events. However, the pulmonary arterial hypertension (PAH) guidelines do not suggest any strategy to overcome treprostinil-induced thrombocytopenia. Selexipag is an oral, non-prostanoid, selective IP receptor agonist. This is the first case report proposing the use of selexipag, due to its minimal thrombocytopenia risk, when severe treprostinil-induced thrombocytopenia occurs in practice. A 66-year-old woman presented to the hospital with new-onset PAH and right ventricular dysfunction. Due to the high mortality risk, the patient was initially started on intravenous treprostinil. The clinical course was complicated by probable treprostinil-induced thrombocytopenia. Due to the need for prostacyclin pathway therapy, the decision was made to switch from intravenous treprostinil to oral selexipag. The nadir platelet count was 30,000/μL. Approximately 72 h after discontinuation of treprostinil and maintaining selexipag 1600 mcg twice daily, the platelet count improved to 46,000/μL on the day of discharge. Several days after discharge, the platelet count further improved to 55,000/μL. The repeated platelet count 1 month after discharge normalized to 329,000/μL. Our case report described the successful use of selexipag to overcome treprostinil-induced thrombocytopenia, owing to its limited effect on platelet aggregation.
DOI: 10.1002/phar.70222
Authors: Kazuhiko Kido(Conceptualization, Data curation, Investigation, Writing – original draft, Writing – review & editing), Anantha Madgula(Conceptualization, Investigation, Writing – original draft, Writing – review & editing), James C. Coons(Conceptualization, Validation, Writing – original draft, Writing – review & editing), Marco Caccamo(Conceptualization, Writing – original draft, Writing – review & editing), George Sokos(Conceptualization, Supervision, Writing – original draft, Writing – review & editing)
Institutions: West Virginia University, University of Pittsburgh
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7236634434
